EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variation of hemolysin co-regulated protein 1 affects the immunogenicity and pathogenicity of Burkholderia pseudomallei

Sarunporn Tandhavanant, Thatcha Yimthin, Sineenart Sengyee, Ratana Charoenwattanasatien, Andrey A Lebedev, Eric R Lafontaine, Robert J Hogan, Claire Chewapreecha, T Eoin West, Paul J Brett, Mary N Burtnick, Narisara Chantratita iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Sarunporn Tandhavanant und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Melioidosis, Genetic Variation, Bacterial Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemolysin co-regulated protein 1 (Hcp1) is a component of the cluster 1 Type VI secretion system (T6SS1) that plays a key role during the intracellular lifecycle of Burkholderia pseudomallei . Hcp1 is recognized as a promising target antigen for developing melioidosis diagnostics and vaccines. While the gene encoding Hcp1 is retained across B . pseudomallei strains, variants of hcp1 have recently been identified. This study aimed to examine the prevalence of hcp1 variants in clinical isolates of B . pseudomallei , assess the antigenicity of the Hcp1 variants, and the ability of strains expressing these variants to stimulate multinucleated giant cell (MNGC) formation in comparison to strains expressing wild-type Hcp1 (Hcp1 wt ). Sequence analysis of 1,283 primary clinical isolates of B . pseudomallei demonstrated the presence of 8 hcp1 alleles encoding three types of Hcp1 proteins, including Hcp1 wt (98.05%), Hcp1 variant A (1.87%) and Hcp1 variant B (0.08%). Compared to strains expressing Hcp1 wt , those expressing the dominant variant, Hcp1 variant A , stimulated lower levels of Hcp1 variant A -specific antibody responses in melioidosis patients. Interestingly, when Hcp1 variant A was expressed in B . pseudomallei K96243, this strain retained the ability to stimulate MNGC formation in A549 cells. In contrast, however, similar experiments with the Hcp1 variant B demonstrated a decreased ability of B . pseudomallei to stimulate MNGC formation. Collectively, these results show that B . pseudomallei strains expressing variants of Hcp1 elicit variable antibody responses in melioidosis patients and differ in their ability to promote MNGC formation in cell culture.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkholderia pseudomalleiMelioidosisGenetic VariationBacterial ProteinsHumansVirulenceAntibodies, Bacterial

Substanzen

Bacterial ProteinsAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Department of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada, United States of America.
  • Beamline Division, Synchrotron Light Research Institute, (Public Organization), Nakhon Ratchasima, Thailand.
  • Center for Biomolecular Structure, Function and Application, Suranaree University of Technology, Nakhon Ratchsima, Thailand.
  • CCP4, Research Complex at Harwell, UKRI-STFC Rutherford Appleton Laboratory, Harwell, Didcot, United Kingdom.

ORCID-Profile: Narisara Chantratita

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • Mahidol University
  • National Institutes of Health
  • Defense Threat Reduction Agency

Zitieren

APA

Tandhavanant, S., Yimthin, T., Sengyee, S., Charoenwattanasatien, R., Lebedev, A. A., Lafontaine, E. R., Hogan, R. J., Chewapreecha, C., West, T. E., Brett, P. J., Burtnick, M. N., & Chantratita, N. (2025). Genetic variation of hemolysin co-regulated protein 1 affects the immunogenicity and pathogenicity of Burkholderia pseudomallei. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012758

Vancouver

Tandhavanant S, Yimthin T, Sengyee S, Charoenwattanasatien R, Lebedev AA, Lafontaine ER, et al. Genetic variation of hemolysin co-regulated protein 1 affects the immunogenicity and pathogenicity of Burkholderia pseudomallei. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012758

BibTeX
@article{Tandhavanant2025,
  author = {Tandhavanant, Sarunporn and Yimthin, Thatcha and Sengyee, Sineenart and Charoenwattanasatien, Ratana and Lebedev, Andrey A and Lafontaine, Eric R and Hogan, Robert J and Chewapreecha, Claire and West, T Eoin and Brett, Paul J and Burtnick, Mary N and Chantratita, Narisara},
  title = {Genetic variation of hemolysin co-regulated protein 1 affects the immunogenicity and pathogenicity of Burkholderia pseudomallei},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012758}
}
Kostenlos starten →